business buildings

FDA Classifies Baxter’s Hospital Bed System Recall As Most Serious

The U.S. health regulator on Wednesday classified the recall of hospital bed systems by Baxter International Inc (BAX.N), as the most serious type, on concerns it could lead to life-threatening injuries or death.  Baxter initiated the recall of its WatchCare Incontinence Management System, which is used to discreetly alert an incontinent patient’s caregiver of involuntary urination or defecation, by sending a correction letter to its customers in late September. Read more.

Source: Reuters, November 23, 2022

business buildings

Coloplast to Introduce SpeediCath Flex Set Catheter in US

Danish medical device company Coloplast is set to launch its new SpeediCath Flex Set catheter in the US this month. The new catheter is a gentle, all-in-one solution that has been developed for people living with bladder and urinary problems. It features a no-touch dry sleeve as well as an omnidirectional tip, which can bend to follow the curves of the urethra.  The SpeediCath Flex Set has a soft-squeeze grip that safely guides the tip into the urethra without making contact. It helps patients catheterise at home or away and also supports them in managing conditions and sustaining healthy lifestyles. Read more.

Source: Medical Device Network, November 21, 2022

TENA logo Essity

TENA Launches Lights Sensitive Ultra Pads Tackling a Lesser-Known Menopause Symptom

TENA, the UKs leading incontinence brand for over 60 years, has launched a new range of Lights Sensitive Ultra Pads, designed to manage bladder leaks and support healthy intimate skin. This latest product innovation features a unique skin caring emulsion that has been specifically designed for sensitive skin by helping to limit friction, making it the first of its kind to the UK market. Continuing in its mission to better support women during the menopause, the introduction of the TENA Lights Sensitive Ultra will help the large number of women who suffer with skin irritation and incontinence – two of the many lesser-known menopausal symptoms. Read more.

Source: Retail Times, November 19, 2022

disabled caregiving

PBE, Elizabeth Dole Foundation Exceed Goal to Benefit Veterans, Caregivers by Nearly $100,000

Ohio-based incontinence product manufacturer Principle Business Enterprises, Inc. (PBE), and the Elizabeth Dole Foundation, a Washington, DC, nonprofit that advocates for military caregivers, exceeded their joint goal for a year-long fundraising drive, with contributions totaling $295,000 to provide essential relief to these “Hidden Heroes.”  Earmarked for the foundation’s “Respite Relief for Military and Veteran Caregivers” program that gives qualifying caretakers a much-needed break, the money will directly benefit an estimated 340 military families and indirectly impact more than 1000 individuals. Respite Relief recipients – spouses, parents, relatives and friends who take care of America’s wounded, ill and injured veterans – enjoy 35 hours of free help from in-home care professionals. Read more.

Source Nonwovens Industry, November 18, 2022

bacteria biofilm indwelling catheter

Urinary Tract Infections: A New Antibiotic May Be on the Way to Treat UTIs

A new type of antibiotic for treating urinary tract infections (UTIs) may be available sooner than expected. Gepotidacin, manufactured by the pharmaceutical company GSK, is being described as “novel” or “first-in-class” because of how it works to prevent or slow bacterial DNA replication. If approved, gepotidacin would be the first new antibiotic developed for treating UTIs in more than 20 years. It would also be available at least a year ahead of the estimated study completion date. Read more.

Source: healthline, November 8, 2022

business buildings

BioDerm, Inc. Begins Distribution in Home Care Markets of a New Revolutionary Female Incontinence Device From TillaCare, Ltd

BioDerm is excited to partner with TillaCare as a U.S. distributor of TillaCare’s UriCap Female. UriCap Female is a revolutionary external urine collection system offering female patients with urinary incontinence a comfortable, easy-to-use solution without the skin irritation and discomfort associated with absorbent products. Following the successful launch of UriCap Female in hospital and institutional settings, BioDerm launched a direct-to-consumer campaign allowing patients to receive UriCap Female for in-home use. Read more.

Source: Index-Journal, October 28, 2022

Adult absorbent incontinence products

Henkel Qhesive Solutions Reveals Promising Trial Results for Smart Adult Care

In the face of an aging population, smart technology will play a vital role in improving elder individuals’ quality of life and dignity, Henkel Qhesive Solutions has demonstrated how innovation will be helping to address the challenge of caring for those affected by incontinence: A long term trial of Smart Adult Care recently run in a nursing home in Italy has shown that digital diapers can improve the patient’s wellbeing through more timely changes, while allowing staff to focus on delivering better care. Read more.

Source: Nonwovens Industry, October 20, 2022

clinical medical

Neuspera Medical® Announces First Successful Implant of the Nuvella™ System in the Second Phase of Its SANS-UUI IDE Clinical Trial

Neuspera® Medical, a medical device company developing implantable devices for patients battling chronic illnesses, today announced the first patient successfully implanted with the Nuvella™ system in its pivotal clinical trial (SANS-UUI). The procedure was performed by Dr. Jodi Michaels of Minnesota Urology, St. Paul, MN. The study will evaluate the safety and efficacy of the Nuvella system, designed to treat overactive bladder (OAB) with sacral neuromodulation (SNM) in patients with urinary urgency incontinence (UUI) symptoms. Read more.

Source: PRNewsire, October 10, 2022

woman

Urolon, A New Treatment for Female Stress Urinary Incontinence, Launches in the UK

Stress Urinary Incontinence (SUI) is the most common type of urinary incontinence. According to estimations around 1 in 3 women will experience bladder leakage at some point in their life. SUI happens when the sphincter muscle that controls the urethra, the pelvic floor tissues and muscles that are used to keep the urethra closed, weakens. Urolon developed by Netherlands-based AQLANE Medical, is solving for this.  Urolon is a bioresorbable, non-permanent filler that is completely removed from your body over time. The treatment is minimally invasive, takes around 20 minutes and can be performed in a hospital or clinic. Three small injections into the urethral wall restore its closure. Read more.

Source: FemTech Insider, October 6, 2022

bacteria biofilm indwelling catheter

Why People with Diabetes Have More UTIs and How to Prevent Infections

Infections, especially urinary tract infections (UTIs), are common experiences for people with diabetes. UTIs are also often more severe in people with diabetes than they are in those without diabetes. UTIs may lead to serious kidney problems in those with diabetes, such as renal abscesses, emphysematous cystitis and pyelonephritis, and renal papillary necrosis. Read more.

Source: Medical News Today, September 27, 2022